Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

MARSEILLE, France, May 13, 2026–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its business update and consolidated financial results for the quarter ending March 31, 2026.Read More